Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 93
Filter
1.
Schweiz Arch Tierheilkd ; 154(3): 105-11, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22378051

ABSTRACT

Eighteen client-owned dogs undergoing Tibial Plateau Leveling Osteotomy (TPLO) were included in this blinded clinical study and randomly assigned to one of two treatment groups. Group C (carprofen) received intravenous (IV) carprofen, 4 mg/kg, prior to anesthesia, whereas group P (placebo) received IV saline. General anesthesia was maintained with isoflurane in oxygen and a constant rate infusion (CRI) of sufentanyl IV. Intra-operatively, assessment of nociception was based on changes in physiological parameters and on the analgesics requirement, whereas in the post-operative period evaluation of pain was performed by using a Hellyer and Gaynor pain score and by comparing the doses of rescue buprenorphine required by the two treatment groups. Although no statistically significant differences in intra-operative sufentanyl doses were found between treatment groups, group C had superior cardiovascular stability, and lower post-operative pain scores and rescue buprenorphine doses than group P. Our results indicate that administration of carprofen prior to surgery was effective in improving peri-operative analgesia in dogs undergoing TPLO.


Subject(s)
Analgesia/veterinary , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Carbazoles/administration & dosage , Dogs/physiology , Dogs/surgery , Osteotomy/veterinary , Analgesia/methods , Animals , Anterior Cruciate Ligament/surgery , Anterior Cruciate Ligament Injuries , Blood Pressure/drug effects , Heart Rate/drug effects , Osteotomy/methods , Pain, Postoperative/prevention & control , Pain, Postoperative/veterinary , Perioperative Care/veterinary , Rupture/surgery , Rupture/veterinary , Tibia/surgery
3.
Radiol Med ; 113(8): 1085-95, 2008 Dec.
Article in English, Italian | MEDLINE | ID: mdl-18953635

ABSTRACT

The clinical use of breast magnetic resonance (MR) imaging is increasing, especially for applications requiring paramagnetic contrast-agent injection. This document presents a synthetic list of acceptable indications with potential advantages for women according to evidence from the literature and the expert opinion of the panel that developed this statement. We generally recommend that breast MR imaging be performed in centres with experience in conventional breast imaging [mammography and ultrasonography (US)] and needle-biopsy procedures (under stereotactic or US guidance) as well as in breast MR imaging and second-look US for findings not revealed by conventional imaging performed before MR imaging. In our opinion, there is no evidence in favour of breast MR imaging as a diagnostic tool to characterise equivocal findings at conventional imaging when needle-biopsy procedures can be performed, nor for the study of asymptomatic, non-high-risk women with negative conventional imaging. After a description of technical and methodological requirements, we define the indications and limitations of breast MR imaging for surveillance of high-risk women, local staging before surgery, evaluation of the effect of neoadjuvant chemotherapy, breast previously treated for carcinoma, carcinoma of unknown primary syndrome, nipple discharge and breast implants.


Subject(s)
Breast Neoplasms/diagnosis , Magnetic Resonance Imaging , Female , Humans
4.
Phys Med Biol ; 52(5): 1387-407, 2007 Mar 07.
Article in English | MEDLINE | ID: mdl-17301461

ABSTRACT

The performance of an automatic software package was evaluated with phantom images acquired by a full-field digital mammography unit. After the validation, the software was used, together with a Leeds TORMAS test object, to model the image acquisition process. Process modelling results were used to evaluate the sensitivity of the method in detecting changes of exposure parameters from routine image quality measurements in digital mammography, which is the ultimate purpose of long-term reproducibility tests. Image quality indices measured by the software included the mean pixel value and standard deviation of circular details and surrounding background, contrast-to-noise ratio and relative contrast; detail counts were also collected. The validation procedure demonstrated that the software localizes the phantom details correctly and the difference between automatic and manual measurements was within few grey levels. Quantitative analysis showed sufficient sensitivity to relate fluctuations in exposure parameters (kV(p) or mAs) to variations in image quality indices. In comparison, detail counts were found less sensitive in detecting image quality changes, even when limitations due to observer subjectivity were overcome by automatic analysis. In conclusion, long-term reproducibility tests provided by the Leeds TORMAS phantom with quantitative analysis of multiple IQ indices have been demonstrated to be effective in predicting causes of deviation from standard operating conditions and can be used to monitor stability in full-field digital mammography.


Subject(s)
Artificial Intelligence , Mammography/instrumentation , Mammography/methods , Quality Assurance, Health Care/methods , Radiographic Image Enhancement/methods , Radiographic Image Interpretation, Computer-Assisted/methods , Phantoms, Imaging , Radiographic Image Enhancement/instrumentation , Reproducibility of Results , Sensitivity and Specificity
5.
Phys Med Biol ; 51(17): 4233-51, 2006 Sep 07.
Article in English | MEDLINE | ID: mdl-16912379

ABSTRACT

Early manifestation of breast cancer is often very subtle and is displayed in a complex and variable pattern of normal anatomy that may obscure the disease. The use of dual-energy techniques, that can remove the structural noise, and contrast media, that enhance the region surrounding the tumour, could help us to improve the detectability of the lesions. The aim of this work is to investigate the use of an iodine-based contrast medium in mammography with two different double exposure techniques: K-edge subtraction mammography and temporal subtraction mammography. Both techniques have been investigated by using an ideal source, like monochromatic beams produced at a synchrotron radiation facility and a clinical digital mammography system. A dedicated three-component phantom containing cavities filled with different iodine concentrations has been developed and used for measurements. For each technique, information about the minimum iodine concentration, which provides a significant enhancement of the detectability of the pathology by minimizing the risk due to high dose and high concentration of contrast medium, has been obtained. In particular, for cavities of 5 and 8 mm in diameter filled with iodine solutions, the minimum concentration needed to obtain a contrast-to-noise ratio of 5 with a mean glandular dose of 2 mGy has been calculated. The minimum concentrations estimated with monochromatic beams and K-edge subtraction mammography are 0.9 mg ml(-1) and 1.34 mg ml(-1) for the biggest and smallest details, respectively, while for temporal subtraction mammography they are 0.84 mg ml(-1) and 1.31 mg ml(-1). With the conventional clinical system the minimum concentrations for the K-edge subtraction mammography are 4.13 mg ml(-1) (8 mm diameter) and 5.75 mg ml(-1) (5 mm diameter), while for the temporal subtraction mammography they are 1.01 mg ml(-1) (8 mm diameter) and 1.57 mg ml(-1) (5 mm diameter).


Subject(s)
Algorithms , Contrast Media/chemistry , Iodine/chemistry , Subtraction Technique , Dose-Response Relationship, Drug , Humans , Mammography/instrumentation , Mammography/methods , Phantoms, Imaging , Quality Control , Radiation Dosage , Radiographic Image Enhancement/methods
7.
Phys Med Biol ; 48(13): 1945-56, 2003 Jul 07.
Article in English | MEDLINE | ID: mdl-12884927

ABSTRACT

A dual-energy technique which employs the basis decomposition method is being investigated for application to digital mammography. A three-component phantom, made up of plexiglas, polyethylene, and water, was doubly exposed with the full-field digital mammography system manufactured by General Electric. The 'low' and 'high' energy images were recorded with a Mo/Mo anode-filter combination and a Rh/Rh combination, respectively. The total dose was kept within the acceptable levels of conventional mammography. The first hybrid images obtained with the dual-energy algorithm are presented in comparison with a conventional radiograph of the phantom. Image-quality characteristics at contrast cancellation angles between plexiglas and water are discussed. Preliminary results show that a combination of a standard Mo-anode 28 kV radiograph with a Rh-anode 49 kV radiograph provides the best compromise between image-quality and dose in the hybrid image.


Subject(s)
Diagnostic Imaging/methods , Mammography/instrumentation , Mammography/methods , Algorithms , Calibration , Contrast Media/pharmacology , Models, Statistical , Phantoms, Imaging , X-Rays
9.
J Exp Clin Cancer Res ; 21(3 Suppl): 115-24, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12585665

ABSTRACT

This report presents the preliminary results of the first phase (21 months) of a multi-centre, non-randomised, prospective study, aimed at evaluating the effectiveness of contrast-enhanced magnetic resonance imaging (MRI), X-ray mammography (XM) and ultrasound (US) in early diagnosis of breast cancer (BC) in subjects at high genetic risk. This Italian national trial (coordinated by the Istituto Superiore di Sanità, Rome) so far recruited 105 women (mean age 46.0 years; median age 51.0; age range 25-77 years), who were either proven BRCA1 or BRCA2 mutation carriers or had a 1 in 2 probability of being carriers (40/105 with a previous personal history of BC). Eight cases of breast carcinomas were detected in the trial (mean age 55.3 years, median age 52.5; age range 35-70 years; five with previous personal history of BC). All trial-detected BC cases (8/8) were identified by MRI, while XM and US correctly classified only one. MRI had one false positive case, XM and US none. Seven "MRI-only" detected cancers (4 invasive, 3 in situ) occurred in both pre- (n = 2) and post-menopausal (n = 5) women. With respect to the current XM screening programmes addressed to women in the age range 50-69 years, the global incidence of BC in the trial (7.6%) was over ten-fold higher. The cost per "MRI-only" detected cancer in this particular category of subjects at high genetic risk was substantially lower than that of an XM-detected cancer in the general women population. These preliminary results confirmed that MRI is a very useful tool to screen subjects at high genetic risk for breast carcinoma, not only in pre-, but also in post-menopausal age, with a low probability of false positive cases.


Subject(s)
Breast Neoplasms/diagnosis , Magnetic Resonance Imaging , Mass Screening , Adult , Breast Neoplasms/genetics , Breast Neoplasms/pathology , False Positive Reactions , Female , Gadolinium , Genes, BRCA1 , Genes, BRCA2 , Genetic Predisposition to Disease , Humans , Mammography , Mass Screening/economics , Middle Aged , Mutation , Prospective Studies , Radiographic Image Enhancement , Ultrasonography, Mammary
11.
Am J Psychiatry ; 158(3): 489-92, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11229996

ABSTRACT

OBJECTIVE: The authors address whether a possible age-at-onset cohort effect may have introduced a bias into anticipation studies of schizophrenia. METHOD: A retrospective review of the medical records of all admissions for psychotic disorders (N=877) was conducted. All subjects with a confirmed DSM-IV diagnosis of schizophrenia and age-at-onset data were included (N=419). For analyses, subjects were placed into one of three successive birth cohorts: 1905-1944 (N=96), 1945-1964 (N=200), and 1965-1984 (N=123). RESULTS: The mean age at first appearance of psychotic symptoms and, similarly, the mean age at first hospitalization significantly decreased over time in successive birth cohorts (25.3, 23.3, and 20.4 years, respectively, for age at first appearance of psychotic symptoms). CONCLUSIONS: This potential birth cohort effect for age at onset of schizophrenia needs to be incorporated into genetic models.


Subject(s)
Schizophrenia/epidemiology , Adult , Age Factors , Age of Onset , Cohort Effect , Cohort Studies , Comorbidity , Family , Female , France/epidemiology , Hospital Records/statistics & numerical data , Hospitalization/statistics & numerical data , Humans , Male , Models, Genetic , Prevalence , Retrospective Studies , Schizophrenia/diagnosis , Schizophrenia/genetics , Substance-Related Disorders/diagnosis , Substance-Related Disorders/epidemiology
12.
J Endocrinol Invest ; 22(10): 740-6, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10614522

ABSTRACT

The purpose of the present study was to assess the presence and the time-course of contrast-enhancement in the pituitary gland and pituitary stalk of 24 patients with isolated growth hormone (GH) deficiency and multiple pituitary hormone deficiency. The patients were evaluated clinically (auxological measurements), endocrinologically (spontaneous GH secretion and GH stimulation tests) and with conventional MRI scans. In addition, fast-framing dynamic magnetic resonance imaging (MRI) with Gd-DTPA enhancement was used to quantitate the time course of contrast enhancement within the neurohypophysis, pituitary stalk, postero-superior adenohypophysis and antero-inferior adenohypophysis. In 3 patients without evidence of abnormalities at normal conventional MRI scans (normal anterior lobe and pituitary stalk, normal posterior lobe) and a high response to the GRF provocation test, sequential time-resolved Gd-enhanced MRI demonstrates reduced contrast enhancement in the pituitary stalk. These findings are consistent with impairment in stalk vasculature, presumably located at the level of the portal venous system, and could play a role in the pathogenesis of pituitary hormonal deficiency.


Subject(s)
Growth Disorders/diagnosis , Human Growth Hormone/deficiency , Magnetic Resonance Imaging/methods , Child , Female , Humans , Male , Pituitary Gland/pathology
13.
Diabetes Care ; 22(2): 191-7, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10333932

ABSTRACT

OBJECTIVE: To evaluate the clinical effects of a comprehensive prepackaged meal plan, incorporating the overall dietary guidelines of the American Diabetes Association and other national health organizations, relative to those of a self-selected diet based on exchange lists in free-living individuals with type 2 diabetes. RESEARCH DESIGN AND METHODS: A total of 202 women and men (BMI < or = 42 kg/m2) whose diabetes was treated with diet alone or an oral hypoglycemic agent were enrolled at 10 medical centers. After a 4-week baseline period, participants were randomized to a nutrient-fortified prepared meal plan or a self-selected exchange-list diet for 10 weeks. On a caloric basis, both interventions were designed to provide 55-60% carbohydrate, 20-30% fat, and 15-20% protein. At intervals, 3-day food records were completed, and body weight, glycemic control, plasma lipids, and blood pressure were assessed. RESULTS: Food records showed that multiple nutritional improvements were achieved with both diet plans. There were significant overall reductions in body weight and BMI, fasting plasma glucose and serum insulin, fructosamine, HbA1c, total and LDL cholesterol, and blood pressure (P < 0.001 or better for all). In general, differences in major end points between the diet plans were not statistically significant. CONCLUSIONS: Glycemic control and cardiovascular risk factors improve in individuals with type 2 diabetes who consume diets in accordance with the American Diabetes Association guidelines. The prepared meal program was as clinically effective as the exchange-list diet. The prepared meal plan has the additional advantages of being easily prescribed and eliminating the complexities of meeting the multiple dietary recommendations for type 2 diabetes management.


Subject(s)
Diabetes Mellitus, Type 2/diet therapy , Diet, Diabetic , Food Preferences , Adult , Aged , Blood Glucose/metabolism , Blood Pressure , Body Weight , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/physiopathology , Diet Records , Energy Intake , Female , Fructosamine/blood , Glycated Hemoglobin/analysis , Humans , Hypoglycemic Agents/therapeutic use , Lipids/blood , Male , Middle Aged , Risk Factors , United States , Voluntary Health Agencies
14.
Radiol Med ; 98(4): 255-8, 1999 Oct.
Article in Italian | MEDLINE | ID: mdl-10615363

ABSTRACT

PURPOSE: We evaluated the results obtained by 130 Italian radiologists undergoing a proficiency test of clinical mammography. MATERIAL AND METHODS: Radiologists were invited to report a series of 100 mammograms (two views), including 32 cancers and 78 non-cancers, with limited information regarding age, subjective symptoms, and findings at palpation. Sensitivity and specificity were then calculated. The test was validated by a panel of experts, and standards for test sufficiency were established on that basis (sensitivity > 80%, specificity > 85%). The tested radiologists differed by mammographic practice (average = 5.7 years, range 0.5-18), total number of mammograms read (average = 8,784, range 300-50,000) and per year (average = 1,535 range 300-5,000). RESULTS: Sensitivity (standard > 80%, average 81.1%, range 39-100%) and specificity (standard > 85%, average 84.0%, range 38-98%) standards were reached by 79 (60.8%) and 81 (62.3%) radiologists, respectively. Overall, only 37 (28.5%) radiologists passed the test (reached both standards). Mammographic practice (years of experience) (chi 2 for trend 5.26, p = 0.02), total mammograms read (chi 2 5.86, p = 0.05), and mammograms read per year (chi 2 8.07, p = 0.01) significantly correlated with a sufficient test. DISCUSSION: The evaluated sample is rather large but not necessarily representative of Italian radiologists. Had the sample been selected, there is no way to know if the results would have been biased towards a better or worse figure with respect to the national average. A significant correlation was found with reading experience (the best results were obtained by operators with > 10,000 films read and with > 2,000 films read/year), as which is important because most Italian radiologists reporting mammography usually read a limited number of cases. CONCLUSIONS: These results on such a wide sample of radiologists, possibly representative of the national average, are disappointing, and suggest that the average quality of mammography reporting in Italy may not be up to standards. Thus, we suggest that quality control program for clinical mammography not only test the equipment but include training and accreditation of radiologists.


Subject(s)
Clinical Competence , Mammography , Humans , Italy , Mammography/standards , Quality Control , Sensitivity and Specificity
15.
J Acquir Immune Defic Syndr ; 22(4): 358-63, 1999 Dec 01.
Article in English | MEDLINE | ID: mdl-10634197

ABSTRACT

Indinavir therapy has demonstrated promise in the treatment of HIV-1 infection in clinical trials; however, its efficacy in a U.S. Veterans Affairs Medical Center, where access to therapy is generally unimpeded, is unknown. A review of the Miami cohort was conducted for the year beginning May 1996 to evaluate response to indinavir plus two nucleoside analogues. Of 483 HIV-1-positive patients (97% male; mean age, 46.7+/-9.7 years), 266 were offered indinavir based on their having CD4 counts <200 cells/microl or viral loads >10,000 copies/ml. Of these patients, 36% were adherent and experienced significant reductions in viral loads (-93,325+/-147,911 copies/ml) and elevations in CD4+ (111+/-103 cells/microl) and CD8+ (225+/-338 cells/microl) T cell counts. Adherent patients with baseline CD4 counts <100 cells/microl were 4.5 times more likely to have follow-up viral loads >10,000 copies/ml than those with CD4 >200 cells/microl. Adherent patients with CD4 counts <100 cells/microl did not show evidence of immune "exhaustion" because they were equal to those with CD4 counts >200 cells/microl in their capacity to replenish CD4 cells. Nonadherence to the regimen resulted in loss of therapeutic benefit and suggested that strategies to enhance adherence may become an essential component of treatment.


Subject(s)
HIV Infections/drug therapy , HIV Infections/physiopathology , HIV Protease Inhibitors/therapeutic use , HIV-1 , Indinavir/therapeutic use , Patient Compliance , Adult , CD4 Lymphocyte Count , Disease Progression , Drug Therapy, Combination , Female , HIV Infections/immunology , HIV Infections/virology , HIV-1/physiology , Hospitals, Urban , Hospitals, Veterans , Humans , Male , Middle Aged , Reverse Transcriptase Inhibitors/therapeutic use , Treatment Outcome , United States , United States Department of Veterans Affairs , Viral Load
16.
Minerva Pediatr ; 50(5): 147-50, 1998 May.
Article in Italian | MEDLINE | ID: mdl-9842210

ABSTRACT

BACKGROUND: In the last years thalassemic patients gained a good improvement in prognosis and life style. However, short stature and hypogonadism are still frequent endocrine problems in this population. METHODS: In a group of eleven thalassemic males (14-18 years old), the spontaneous nocturnal endocrine patterns of LH and FSH and plasma gonadotropins in response to GnRH were studied. The profiles were analyzed using a computer program (PULSAR) to determine the secretion pattern (number and amplitude of peaks) and the area under the curve above the secretion baseline (AUC). The endocrine status was compared with liver fibrosis, iron overload and transfusional regimen. RESULTS: A regular and homogeneous transfusion and chelation management often does not prevent pubertal failure; it is related with the degree of liver fibrosis and often it is due to hypothalamic and/or pituitary dysfunction. CONCLUSIONS: Spontaneous gonadotropin profiles can be useful to evaluate hypogonadotropic hypogonadism in order to start the correct treatment.


Subject(s)
Follicle Stimulating Hormone/blood , Luteinizing Hormone/blood , beta-Thalassemia/blood , beta-Thalassemia/therapy , Adolescent , Humans , Hypogonadism/blood , Hypogonadism/diagnosis , Male
19.
Radiol Med ; 92(6): 677-81, 1996 Dec.
Article in Italian | MEDLINE | ID: mdl-9122453

ABSTRACT

To study ankle and hindfoot involvement, we used Computed Tomography (CT) in 38 rheumatoid arthritis (RA) patients (32 women, 6 men, mean age: 56.3 +/- 10.1 years, mean disease duration: 9.9 +/- 6 years) all presenting a definite clinical disease of these joints. The scans were performed on 3rd generation CT equipment (GE ProSpeed SX), with coronally oriented scans 3 mm thick. Bone erosions and joint space narrowing (present/absent) of both talocrural and posterior talocalcaneal joints were assessed and heel valgus angle was measured. Ankle changes (erosion plus joint narrowing) were observed in 15 patients (39.5%, 17 of 76 lower limbs), talocalcaneal changes in 18 (47.4%, 31 lower limbs) and valgus deformity of the hindfoot in 22 (57.9%, 40 lower limbs). Involvement of talocrural and talocalcaneal joints as well as alignment abnormalities were symmetrical in 13.3%, 77.8% and 81.8% of the cases, respectively. All the CT findings were significantly related to disease duration (p = 0.02) and hindfoot injuries to Ritchie index too (p < 0.05). No relationship with seropositivity was observed. Our study confirms that radiographic changes do not entirely mirror clinical evidence and shows that CT does not represent a routine examination for RA patients, but could be reserved to those with prolonged disease or severe heel deformity to plan surgery.


Subject(s)
Arthritis, Rheumatoid/diagnostic imaging , Tarsal Joints/diagnostic imaging , Adult , Aged , Female , Humans , Male , Middle Aged , Tomography, X-Ray Computed
20.
Diabetes Care ; 19(9): 1004-5, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8875098

ABSTRACT

OBJECTIVE: To examine the effect of a single high oral dose of the novel noncaloric sweetener sucralose on short-term glucose homeostasis in patients with IDDM or NIDDM. RESEARCH DESIGN AND METHODS: A total of 13 IDDM and 13 NIDDM patients with glycosylated hemoglobin levels < 10% completed this double-blind cross-over study. After an overnight fast, patients were administered opaque capsules containing either 1,000 mg sucralose or cellulose placebo, followed by a standardized 360-kcal liquid breakfast. Plasma glucose and serum C-peptide levels were measured over the next 4 h. RESULTS: Regardless of the type of diabetes, areas under the curves for changes of plasma glucose and serum C-peptide levels after sucralose administration were not significantly different from those after placebo. During test meals with sucralose, one episode of symptomatic hypoglycemia occurred in each of three IDDM patients, but these episodes were not considered the result of sucralose administration. CONCLUSIONS: The present results support the conclusion that sucralose consumption does not adversely affect short-term blood glucose control in patients with diabetes.


Subject(s)
Blood Glucose/drug effects , Diabetes Mellitus, Type 1/blood , Diabetes Mellitus, Type 2/blood , Sucrose/analogs & derivatives , Sweetening Agents/pharmacology , Administration, Oral , Adult , Blood Glucose/metabolism , C-Peptide/blood , Cross-Over Studies , Double-Blind Method , Fasting , Female , Glycated Hemoglobin/analysis , Homeostasis , Humans , Male , Middle Aged , Sucrose/administration & dosage , Sucrose/pharmacology , Sweetening Agents/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...